Cargando…

HPR205 Future-Proofing European Regulatory and Market Access Practices Based on Learnings From the COVID-19 Pandemic – Stakeholder Perspectives

Detalles Bibliográficos
Autores principales:	Claessens, Z, Beirne, G, Decouttere, C, Vandaele, N, Huys, I, Barbier, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747473/ http://dx.doi.org/10.1016/j.jval.2022.09.1333

Ejemplares similares

SA13 The Impact of the COVID-19 Pandemic on Collaboration and Innovation in Antiviral Drug Development: A Multi-Stakeholder Systems Dynamics Analysis
por: Beirne, G, et al.
Publicado: (2022)

European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
por: Barbier, Liese, et al.
Publicado: (2020)

European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice
por: Barbier, Liese, et al.
Publicado: (2020)

HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil
por: Arcaro, R, et al.
Publicado: (2022)

Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14
por: Godoy, Marcos G, et al.
Publicado: (2013)

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
por: Moorkens, Evelien, et al.
Publicado: (2016)

Advancing sustainable development goals through immunization: a literature review
por: Decouttere, Catherine, et al.
Publicado: (2021)

Emerging Insights into European Markets of Biologics, Including Biosimilars
por: Simoens, Steven, et al.
Publicado: (2022)

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators
por: Saesen, Robbe, et al.
Publicado: (2023)

A Systems-Based Framework for Immunisation System Design: Six Loops, Three Flows, Two Paradigms
por: Decouttere, Catherine, et al.
Publicado: (2021)

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire
por: Van Haesendonck, Lauren, et al.
Publicado: (2023)

HPR214 Challenges of Measuring Healthcare System Resilience
por: Araja, D, et al.
Publicado: (2022)

HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines
por: Bell, E, et al.
Publicado: (2022)

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
por: Saesen, Robbe, et al.
Publicado: (2020)

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells
por: Apraiz, Aintzane, et al.
Publicado: (2011)

The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection
por: Antunes, Ana, et al.
Publicado: (2016)

How Can Authorities Support Distributed Improvisation During Major Crises? A Study of Decision Bottlenecks Arising During Local COVID-19 Vaccine Roll-Out
por: Phillips, Ross Owen, et al.
Publicado: (2022)

Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors
por: Tiberio, Paola, et al.
Publicado: (2017)

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016)

Pharmaceutical market access in emerging markets: concepts, components, and future
por: Kumar, Anuj, et al.
Publicado: (2014)

Genetic analysis and comparative virulence of infectious salmon anemia virus (ISAV) types HPR7a and HPR7b from recent field outbreaks in Chile
por: Godoy, Marcos G, et al.
Publicado: (2014)

Complexity of a complex trait locus: HP, HPR, haemoglobin and cholesterol
por: Guthrie, Philip A.I., et al.
Publicado: (2012)

The general PTS component HPr determines the preference for glucose over mannitol
por: Choe, Mangyu, et al.
Publicado: (2017)

HPR200 The Impact of Community Pharmacies on Regional Equity in Access to Professional Rapid Antigen Testing for SARS-COV-2 in Portugal
por: Guerreiro, J, et al.
Publicado: (2022)

Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
por: Car, Elif, et al.
Publicado: (2023)

Bioeconomy perception by future stakeholders: Hearing from European forestry students
por: Masiero, Mauro, et al.
Publicado: (2020)

Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
por: Hines, Philip A., et al.
Publicado: (2020)

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?
por: Pauwels, Kim, et al.
Publicado: (2014)

PCA-HPR: A principle component analysis model for human promoter recognition
por: Li, Xiaomeng, et al.
Publicado: (2008)

Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?
por: Cazzaniga, Massimiliano, et al.
Publicado: (2012)

Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells
por: Chen, Congcong, et al.
Publicado: (2016)

HPR1 Is Required for High Light Intensity Induced Photorespiration in Arabidopsis thaliana
por: Wang, Zi, et al.
Publicado: (2022)

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
por: Dutta, Binita, et al.
Publicado: (2019)

Dentists greet 'no brainer' investment to boost access and future proof services
Publicado: (2021)

Social movements, stakeholders and non-market strategy
por: Briscoe, Forrest, et al.
Publicado: (2018)

Informing a European guidance framework on electronic informed consent in clinical research: a qualitative study
por: De Sutter, Evelien, et al.
Publicado: (2023)

Future-Proof Regulation against the Test of Time: The Evolution of European Telecommunications Regulation
por: Ibáñez Colomo, Pablo
Publicado: (2022)

Digitizing the Informed Consent Process: A Review of the Regulatory Landscape in the European Union
por: De Sutter, Evelien, et al.
Publicado: (2022)

Transcriptional Activator YesS Is Stimulated by Histidine-phosphorylated HPr of the Bacillus subtilis Phosphotransferase System
por: Poncet, Sandrine, et al.
Publicado: (2009)

Correction: Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells
por: Chen, Congcong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ml7utcmfm8p9oi3pt7u89nvdio